| Inflammation in schizophrenia: a question of balance JC Leza, B García-Bueno, M Bioque, C Arango, M Parellada, K Do, ... Neuroscience & Biobehavioral Reviews 55, 612-626, 2015 | 202 | 2015 |
| Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia B García-Bueno, M Bioque, KS Mac-Dowell, MF Barcones, ... Schizophrenia bulletin 40 (2), 376-387, 2014 | 194 | 2014 |
| Assessing clinical and functional outcomes in a gene–environment interaction study in first episode of psychosis (PEPs) M Bernardo, M Bioque, M Parellada, JS Ruiz, MJ Cuesta, A Llerena, ... Revista de Psiquiatría y Salud Mental (English Edition) 6 (1), 4-16, 2013 | 126 | 2013 |
| Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study MJ Cuesta, AM Sánchez-Torres, B Cabrera, M Bioque, ... Schizophrenia Research 164 (1-3), 65-73, 2015 | 115 | 2015 |
| The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study S Amoretti, M Bernardo, CM Bonnin, M Bioque, B Cabrera, G Mezquida, ... European Neuropsychopharmacology 26 (10), 1638-1648, 2016 | 106 | 2016 |
| Barriers to the use of long-acting injectable antipsychotics in the management of schizophrenia E Parellada, M Bioque CNS drugs 30, 689-701, 2016 | 92 | 2016 |
| Peripheral endocannabinoid system dysregulation in first-episode psychosis M Bioque, B García-Bueno, KS MacDowell, A Meseguer, PA Saiz, ... Neuropsychopharmacology 38 (13), 2568-2577, 2013 | 90 | 2013 |
| BDNF and NGF signalling in early phases of psychosis: relationship with inflammation and response to antipsychotics after 1 year M Martínez-Cengotitabengoa, KS MacDowell, S Alberich, FJ Diaz, ... Schizophrenia bulletin 42 (1), 142-151, 2016 | 81 | 2016 |
| Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative … V Soria, A Gonzalez-Rodriguez, E Huerta-Ramos, J Usall, J Cobo, ... Psychoneuroendocrinology 93, 8-19, 2018 | 77 | 2018 |
| Cognitive reserve as an outcome predictor: First‐episode affective versus non‐affective psychosis S Amoretti, B Cabrera, C Torrent, G Mezquida, A Lobo, A González‐Pinto, ... Acta Psychiatrica Scandinavica 138 (5), 441-455, 2018 | 74 | 2018 |
| Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis M Bioque, MP García-Portilla, C García-Rizo, B Cabrera, A Lobo, ... Schizophrenia Research 193, 188-196, 2018 | 74 | 2018 |
| Age at first episode modulates diagnosis-related structural brain abnormalities in psychosis L Pina-Camacho, Á Del Rey-Mejías, J Janssen, M Bioque, ... Schizophrenia bulletin 42 (2), 344-357, 2016 | 71 | 2016 |
| Clinical, neuroimmunologic, and CSF investigations in first episode psychosis M Guasp, E Giné-Servén, E Maudes, M Rosa-Justicia, ... Neurology 97 (1), e61-e75, 2021 | 67 | 2021 |
| The course of negative symptoms in first-episode schizophrenia and its predictors: a prospective two-year follow-up study G Mezquida, B Cabrera, M Bioque, S Amoretti, A Lobo, A González-Pinto, ... Schizophrenia Research 189, 84-90, 2017 | 59 | 2017 |
| Neutrophil count is associated with reduced gray matter and enlarged ventricles in first-episode psychosis C Núñez, C Stephan-Otto, J Usall, M Bioque, A Lobo, A González-Pinto, ... Schizophrenia Bulletin 45 (4), 846-858, 2019 | 54 | 2019 |
| Modelling gene-environment interaction in first episodes of psychosis M Bernardo, M Bioque, B Cabrera, A Lobo, A González-Pinto, L Pina, ... Schizophrenia research 189, 181-189, 2017 | 54 | 2017 |
| Cognition and psychopathology in first-episode psychosis: are they related to inflammation? B Cabrera, M Bioque, R Penadés, A González-Pinto, M Parellada, ... Psychological medicine 46 (10), 2133-2144, 2016 | 50 | 2016 |
| Targeting hormones for improving cognition in major mood disorders and schizophrenia: thyroid hormones and prolactin M Tost, JA Monreal, A Armario, JD Barbero, J Cobo, C García-Rizo, ... Clinical drug investigation 40 (1), 1-14, 2020 | 49 | 2020 |
| Targeting the microbiome-gut-brain axis for improving cognition in schizophrenia and major mood disorders: A narrative review M Bioque, A González-Rodríguez, C Garcia-Rizo, J Cobo, JA Monreal, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 105, 110130, 2021 | 48 | 2021 |
| Cognitive reserve assessment scale in health (CRASH): its validity and reliability S Amoretti, B Cabrera, C Torrent, CM Bonnín, G Mezquida, M Garriga, ... Journal of clinical medicine 8 (5), 586, 2019 | 47 | 2019 |
Miquel BernardoUniversitat de Barcelona / Hospital Clínic de Barcelona / IDIBAPS / CIBERSAMDirección de correo verificada de clinic.cat
